they improved execution considerably against all expectations - while product revenues remain a complete mess the shares should make some real progress going forward. One third of the market cap is cash by the way.
another 5k short here - stock acting extremely disappointing so far - hoping for a great deal
stock acting very weak despite market going green - doubled up the short bet here - still looking for the shares to end up just around 5% higher - very heavy sell orders in the book currently
there's some upside potential going forward - would expect the shares to hit $18 within a few weeks
shorted some but will switch to long if it takes out pre-market highs
would cover or even go long at after hours levels I suspect upgrades tomorrow given the expectations for another underwhelming quarter and subsequent guide down.
1) still very weak product revenues and even worse management admitted on the call that it would take several quarters to show desired growth levels (if at all)
2) already elevated operating expenses are forecasted to rise even further going forward (causes the eps miss on forward guidance)
3) no revenue growth quarter over quarter projected (but this is still better than expectations)
4) gross margins to come down slightly
5) new CEO might join somewhere in 2015 as the search process still has not finished
Despite all this the stock might be able to catch one or two upgrades tomorrow or at least some small price target raises. If upgrades are indeed issued the stock might easily move up 20-30% tomorrow
the stock is closing at day lows with many momentum traders trapped - this will cause pressure on the shares for some days going forward - would expect the stock to give back the entire gain over the next week (frankly the settlement does change nothing for the company by the way)
you don't get the point here - with the main source of revenues coming from the Gemma power plant unit earnings in fact might vary qoq dependent on the construction progress. Much more important is the backlog number which is down the entire reported revenue number for the quarter which means all of the reported revenues came from backlog conversion while the pipeline was not rebuilt during the quarter.
will be down double digits tomorrow
company still burning cash too fast
no - might close unchanged or even lower - mortgaged their lead drug just to stay afloat for two more years at best. short
call does not work very well so far with one analyst pretty straightforward about his thoughts about the deal as an act of desperation
revenue growth is slowing as well as subscription revenue growth - operating margin is down and will come down even further. Stock should reverse course during the call. Sell.